• ISSN 2320-0901 (Online)
  • Monthly since 2012
  • Open access
  • Double blind peer review
editor@ijrmp.org

Subjects

  • Development of AI-Based Predictive Models for Drug Side Effect Prevention

    The rapid evolution of artificial intelligence (AI) techniques has significantly impacted biomedical research, particularly in drug safety and side effect prevention. This manuscript explores the development of AI-based predictive models that aim to identify and mitigate…

  • Smart Drug Packaging: Enhancing Medication Adherence

    Medication non-adherence remains a persistent challenge in healthcare, contributing to suboptimal therapeutic outcomes and increased healthcare costs. Smart drug packaging, which integrates modern technologies such as sensors, wireless connectivity, and real-time monitoring, is emerging as a…

  • Sustainable Pharmaceutical Logistics: Reducing Carbon Footprint in Drug Distribution

    The pharmaceutical industry is undergoing a significant transformation as sustainability emerges as a critical priority. This study examines the intricate balance between efficient drug distribution and environmental stewardship, focusing on sustainable pharmaceutical logistics. It addresses the…

  • Integration of Augmented Reality (AR) in Pharmaceutical Sales Training

    The rapid evolution of technology in the healthcare industry has led to the integration of innovative approaches for professional training. Augmented Reality (AR) is one such breakthrough that has the potential to revolutionize pharmaceutical sales training…

  • Effects of Probiotics on Drug Absorption and Metabolism

    The interplay between probiotics and drug absorption and metabolism represents an evolving area of pharmaceutical research. Probiotics, defined as live microorganisms that confer health benefits, have traditionally been linked to gastrointestinal and immune functions. However, emerging…

  • Bioavailability Enhancement of Poorly Soluble Drugs Using Lipid Nanoparticles

    The challenge of poor water solubility remains a significant barrier in the pharmaceutical development of many drugs. Lipid nanoparticles have emerged as a promising carrier system to enhance the bioavailability of these drugs by improving solubilization,…

  • Assessing the Effectiveness of AI-Powered Drug Recall Systems

    In recent years, the pharmaceutical industry has experienced rapid technological advancements, particularly in the integration of artificial intelligence (AI) into critical operations such as drug recall management. This study evaluates the effectiveness of AI-powered drug recall…

  • The Adoption of AI in Accelerating Clinical Trial Recruitment

    The integration of artificial intelligence (AI) into clinical trial recruitment represents a paradigm shift in the way researchers identify and enroll participants for clinical studies. This manuscript examines the transformative role of AI technologies—ranging from machine…

  • Potential of Nanosponges in Detoxification of Drug Overdose

    The dramatic rise in drug overdose cases has underscored the urgent need for innovative detoxification strategies. Nanosponges—nanoscale, porous, polymeric particles with the capacity to encapsulate a wide range of molecules—represent a novel therapeutic approach for sequestering…

  • Pharmacogenomics: The Future of Personalized Drug Dosing

    Pharmacogenomics, the study of how genetic variations influence drug response, is revolutionizing personalized medicine. This manuscript explores its potential to transform drug dosing, enhance therapeutic efficacy, and minimize adverse reactions. We review literature up to 2022…